Lyell Immunopharma, Inc. (LYEL) Capital expenditures 2019–2025
Lyell Immunopharma, Inc. (LYEL) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$780,000FY2025 · since FY2019: $16.0M → $780,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $780,000 | +68.1% |
| FY2024 | $464,000 | -82.7% |
| FY2023 | $2.7M | -88.9% |
| FY2022 | $24.3M | -62.9% |
| FY2021 | $65.5M | +27.2% |
| FY2020 | $51.5M | +220.8% |
| FY2019 | $16.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice